SFM
UTHR icon

Systematic Financial Management’s United Therapeutics UTHR Stock Holding History

Systematic Financial Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,830
Closed -$767K – 638
2019
Q2 		$767K Sell
9,830
-550
-5% -$51.4K 0.03% 469
2019
Q1 		$1.22M Sell
10,380
-615
-6% -$71.7K 0.04% 392
2018
Q4 		$1.2M Sell
10,995
-345
-3% -$40K 0.04% 319
2018
Q3 		$1.45M Sell
11,340
-1,170
-9% -$145K 0.04% 353
2018
Q2 		$1.42M Sell
12,510
-425
-3% -$46.7K 0.03% 386
2018
Q1 		$1.45M Buy
12,935
+695
+6% +$88.3K 0.03% 327
2017
Q4 		$1.81M Buy
12,240
+1,045
+9% +$133K 0.04% 286
2017
Q3 		$1.31M Sell
11,195
-2,505
-18% -$320K 0.03% 494
2017
Q2 		$1.78M Buy
13,700
+2,290
+20% +$286K 0.03% 392
2017
Q1 		$1.54M Sell
11,410
-2,320
-17% -$351K 0.03% 515
2016
Q4 		$1.97M Sell
13,730
-40
-0.3% -$5.11K 0.03% 357
2016
Q3 		$1.63M Sell
13,770
-4,045
-23% -$486K 0.02% 480
2016
Q2 		$1.89M Buy
+17,815
New +$1.99M 0.03% 341
2013
Q4 		– Sell
-19,225
Closed -$1.51M – 695
2013
Q3 		$1.51M Sell
19,225
-3,480
-15% -$254K 0.01% 454
2013
Q2 		$1.49M Buy
+22,705
New +$1.46M 0.01% 431

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Systematic Financial Management's UTHR Position: Q3 2019 in Review

Systematic Financial Management sold out of United Therapeutics (UTHR) in Q3 2019, closing a stake of 9,830 shares — an estimated $767K sold.

Systematic Financial Management first reported a position in UTHR in Q2 2013 and held it in 15 quarters. The position peaked at $1.97M in Q4 2016. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

  • Systematic Financial Management reported no remaining United Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Systematic Financial Management sold 9,830 United Therapeutics shares in Q3 2019, an estimated $767K.
  • Systematic Financial Management first reported a position in United Therapeutics in Q2 2013 and held it in 15 quarters.
  • Systematic Financial Management's United Therapeutics position peaked at $1.97M in Q4 2016.
  • 302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Systematic Financial Management's 13F filing for Q3 2019, filed 6 Nov 2019.